When Systems Fail: Lessons from an FDA Warning Letter Drug Safety and Pharmacovigilance Course FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA Enforcement Actions and Managing Non Compliance TS Quality & Engineering New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Compounded "semaglutide" is not FDA approved semaglutide.com